WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011136752) COMBINED PHARMACEUTICAL COMPOSITION COMPRISING CARMOTEROL AND CICLESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/136752    International Application No.:    PCT/TR2011/000111
Publication Date: 03.11.2011 International Filing Date: 25.04.2011
IPC:
A61K 9/00 (2006.01), A61K 31/47 (2006.01), A61K 31/58 (2006.01), A61P 11/00 (2006.01), A61P 11/06 (2006.01), A61P 11/08 (2006.01)
Applicants: BILGIC, Mahmut [TR/TR]; (TR)
Inventors: BILGIC, Mahmut; (TR)
Agent: KARLIDAG, H., Gulben; Tozkoparan Mah. General Ali Riza Gurcan Cad. Merter Is Merkezi Bagimsiz Bolum No: 2/13 Merter/Istanbul 34173 Turkey (TR)
Priority Data:
2010/03236 26.04.2010 TR
Title (EN) COMBINED PHARMACEUTICAL COMPOSITION COMPRISING CARMOTEROL AND CICLESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES
(FR) COMPOSITION PHARMACEUTIQUE COMBINÉE COMPRENANT DU CARMOTÉROL ET DU CICLÉSONIDE POUR LE TRAITEMENT DE MALADIES RESPIRATOIRES
Abstract: front page image
(EN)The present invention relates to the medicament composition comprising a combination of carmoterol and/or a pharmaceutically acceptable derivative thereof and ciclesonide and/or a pharmaceutically acceptable derivative thereof so as to be used in the treatment of respiratory tract diseases, especially in asthma and chronic obstructive pulmonary disease (COPD), and delivery of this pharmaceutical composition.
(FR)La présente invention concerne une composition de médicament comprenant une combinaison de carmotérol et/ou un dérivé pharmaceutiquement acceptable de celui-ci et de ciclésonide et/ou un dérivé pharmaceutiquement acceptable de celui-ci de manière à être utilisé dans le traitement de maladies des voies respiratoires, en particulier dans l'asthme et la bronchopneumopathie chronique obstructive (BPCO), et l'administration de cette composition pharmaceutique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)